The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Systematic Review and Meta-Analysis of Methotrexate Use and Risk of Cardiovascular Disease
Open accessAbstract
Inflammation predicts risk of cardiovascular disease (CVD) events, but the relation of drugs that directly target inflammation with CVD risk is not established. Methotrexate is a disease-modifying anti-rheumatic drug broadly used for treatment of chronic inflammatory disorders. We performed a systematic review and meta-analysis of evidence for relationships of methotrexate with CVD occurrence. Cohorts, case-control studies or randomized trials were included if they reported an association between methotrexate and CVD risk. Inclusions/exclusions were independently adjudicated, and all data were extracted in duplicate. Pooled effects were calculated using inverse-variance-weighted meta-analysis. Of 694 identified publications, 10 observational studies, in which methotrexate was administered among patients with rheumatoid arthritis, psoriasis, or polyarthritis met inclusion criteria. Methotrexate was associated with 21% lower risk of total CVD (n=10 studies, 95% CI=0.73-0.87, p<0.001), and 18% lower risk of myocardial infarction (n=5, 95% CI=0.71-0.96, p=0.01), without evidence for statistical between-study heterogeneity (p=0.30, p=0.33, respectively). Among prespecified sources of heterogeneity explored, stronger associations were observed in studies that adjusted for underlying disease severity (RR=0.64, 95% CI=0.43-0.96, p<0.01), and for other concomitant medication (RR=0.73, 95% CI=0.63-0.84, p<0.001). Publication bias was potentially evident (funnel plot, Begg’s test, p=0.06); excluding studies with extreme risk estimates did not, however, alter results (RR=0.81, 95% CI=0.74-0.89). In conclusion, methotrexate use is associated with lower risk of CVD among patients with chronic inflammation. These findings suggest that a direct treatment of inflammation may reduce CVD risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
Ridker, P. M., Rifai, N., Rose, L., Buring, J. E., & Cook, N. R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021993 · Cited by 3,604
Self-citationA Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis
Bathon, J. M., Martin, R. W., Fleischmann, R. M., Tesser, J. R., Schiff, M. H., Keystone, E. C., Genovese, M. C., Wasko, M. C., Moreland, L. W., Weaver, A. L., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011303432201 · Cited by 1,730
Aviña‐Zubieta, J. A., Choi, H. K., Sadatsafavi, M., Etminan, M., Esdaile, J. M., & Lacaille, D. (2008) · Arthritis Care & Research · doi:10.1002/art.24092 · Cited by 1,462
Micha, R., Wallace, S. K., & Mozaffarian, D. (2010) · Circulation · doi:10.1161/circulationaha.109.924977 · Cited by 1,244
Self-citationInflammatory Markers and the Risk of Coronary Heart Disease in Men and Women
Pai, J. K., Pischon, T., Ma, J., Manson, J. E., Hankinson, S. E., Joshipura, K., Curhan, G. C., Rifai, N., Cannuscio, C. C., Stampfer, M. J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040967 · Cited by 1,174
Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study
Choi, H. K., Hernán, M. A., Seeger, J. D., Robins, J. M., & Wolfe, F. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08213-2 · Cited by 1,127
Self-citationLow-Dose Methotrexate: A Mainstay in the Treatment of Rheumatoid Arthritis
Cronstein, B. N. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.3 · Cited by 535
Patterns of cardiovascular risk in rheumatoid arthritis
Solomon, D. H., Goodson, N. J., Katz, J. N., Weinblatt, M. E., Avorn, J., Setoguchi, S., Canning, C., & Schneeweiss, S. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.050377 · Cited by 412
Self-citationPRODANOWICH, S., MA, F., TAYLOR, J., PEZON, C., FASIHI, T., & KIRSNER, R. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.06.017 · Cited by 384
Evaluation of old and new tests of heterogeneity in epidemiologic meta-analysis
Takkouche, B., Cadarso-Suarez, C., & Spiegelman, D. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009981 · Cited by 380
Westlake, S. L., Colebatch, A. N., Baird, J., Kiely, P., Quinn, M., Choy, E., Ostor, A. J. K., & Edwards, C. J. (2010) · Rheumatology · doi:10.1093/rheumatology/kep366 · Cited by 357
Shea, B., Swinden, M. V., Tanjong Ghogomu, E., Ortiz, Z., Katchamart, W., Rader, T., Bombardier, C., Wells, G. A., & Tugwell, P. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000951.pub2 · Cited by 347
RIDKER, P. M. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03404.x · Cited by 270
Self-citationvan Halm, V. P., Nurmohamed, M. T., Twisk, J. W., Dijkmans, B. A., & Voskuyl, A. E. (2006) · Arthritis Research & Therapy · doi:10.1186/ar2045 · Cited by 267
CAUSE OF DEATH IN RHEUMATOID ARTHRITIS
PRIOR, P., SYMMONS, D. P. M., SCOTT, D. L., BROWN, R., & HAWKINS, C. F. (1984) · Rheumatology · doi:10.1093/rheumatology/23.2.92 · Cited by 247
Antirheumatic drug use and the risk of acute myocardial infarction
Suissa, S., Bernatsky, S., & Hudson, M. (2006) · Arthritis Care & Research · doi:10.1002/art.22094 · Cited by 184
Solomon, D. H., Avorn, J., Katz, J. N., Weinblatt, M. E., Setoguchi, S., Levin, R., & Schneeweiss, S. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22255 · Cited by 181
Self-citationWolfe, F., & Michaud, K. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23811 · Cited by 166
Cardiovascular Manifestations of Rheumatologic Diseases
Roman, M. J., & Salmon, J. E. (2007) · Circulation · doi:10.1161/circulationaha.106.678334 · Cited by 157
Ortiz, Z., Shea, B., Suarez-Almazor, M. E., Moher, D., Wells, G. A., & Tugwell, P. (1999) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000951 · Cited by 126
Nadareishvili, Z., Michaud, K. D., Hallenbeck, J. M., & Wolfe, F. (2008) · Arthritis Care & Research · doi:10.1002/art.23935 · Cited by 120
Chollet-Janin, A., Finckh, A., Dudler, J., & Guerne, P. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22389 · Cited by 80
Troelsen, L. N., Garred, P., MADSEN, H. O., & Jacobsen, S. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22302 · Cited by 66
Zhang, Z., Zhao, P., Li, A., Lv, X., Gao, Y., Sun, H., Ding, Y., & Liu, J. (2009) · Mediators of Inflammation · doi:10.1155/2009/389720 · Cited by 31
Cited by
Agca, R., Heslinga, S. C., Rollefstad, S., Heslinga, M., McInnes, I. B., Peters, M. J. L., Kvien, T. K., Dougados, M., Radner, H., Atzeni, F., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209775 · Cited by 1,380
Pathogenetic insights from the treatment of rheumatoid arthritis
McInnes, I. B., & Schett, G. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31472-1 · Cited by 1,345
Low-Dose Methotrexate for the Prevention of Atherosclerotic Events
Ridker, P. M., Everett, B. M., Pradhan, A., MacFadyen, J. G., Solomon, D. H., Zaharris, E., Mam, V., Hasan, A., Rosenberg, Y., Iturriaga, E., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1809798 · Cited by 1,317
Self-citationInflammation and atherosclerosis: signaling pathways and therapeutic intervention
Kong, P., Cui, Z.-Y., Huang, X.-F., Zhang, D.-D., Guo, R.-J., & Han, M. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00955-7 · Cited by 1,183
“Previous systematic reviews and meta-analyses suggested the significant relationships between methotrexate treatment and a reduced risk of cardiovascular disease.(362) Similarly, a recent study of patients with rheumatoid arthritis showed that methotrexate use is associated with lower cardiovascular outcomes.”
ResultLow Wang, C. C., Hess, C. N., Hiatt, W. R., & Goldfine, A. B. (2016) · Circulation · doi:10.1161/circulationaha.116.022194 · Cited by 1,155
Metadata
- Authors
- Micha, R., Imamura, F., Wyler von Ballmoos, M., Solomon, D. H., Hernán, M. A., Ridker, P. M., & Mozaffarian, D.
- Venue
- The American Journal of Cardiology
- Publisher
- Elsevier BV
- Published
- 2011-11
- Volume
- 108
- Issue
- 9
- Pages
- 1362-1370
- ISSN
- 0002-9149 (ISSN-L)
- OpenAlex
- W2155123856
- Cited by
- 535
- References
- 28
- FWCI
- 5.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.